Articles from NORTHLANE CAPITAL PARTNERS

SAI MedPartners (“SAI”), a global consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries, is pleased to announce that it has acquired The Dunn Group (“TDG”). Northlane Capital Partners (“NCP”) partnered with management to acquire SAI in June 2022.

Northlane Capital Partners (“Northlane” or “NCP”) announced today the final closing of its oversubscribed third private equity fund, Northlane Capital Partners III LP (“NCP III” or “Fund III”), at its hard cap of $750 million. The total raised substantially surpassed Fund III’s $550 million target and reflects notable growth from its $408 million predecessor. Global investors include pension funds, insurance companies, endowments and foundations, asset managers, healthcare institutions, funds of funds, and family offices.

Northlane Capital Partners (“NCP”) announced today the sale of Empower Community Care (“Empower” or the “Company”) to NexPhase Capital, LP (“NexPhase”).

Northlane Capital Partners (“NCP”) announced today the sale of The Difference Card (“TDC” or the Company) to funds managed by Stone Point Capital LLC.

Northlane Capital Partners (“NCP”) announced today that it has made an investment in Plus Delta Partners (“PDP”), a leading provider of specialized fundraising training and tools designed to enable higher education institutions, healthcare organizations, and other nonprofits to maximize donor contributions. NCP invested alongside PDP’s management team and its founder, Guy Hart.

Northlane Capital Partners (“NCP”) announced today that it has invested in United States Drug Testing Laboratories Inc. (“USDTL”), a forensic toxicology laboratory testing for alcohol and substance use. NCP invested alongside USDTL’s management team and its founders, Veronica and Doug Lewis.

SAI MedPartners (“SAI”), a global consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries, is pleased to announce that it has acquired IDEA Pharma (“IDEA”). Northlane Capital Partners (“NCP”) partnered with management to acquire SAI in June 2022.

Northlane Capital Partners (“NCP”) announced today the sale of PAR Excellence Systems Inc. (“PAR”, or the “Company”) to OceanSound Partners. NCP and PAR’s management team will continue as investors in the Company.

Northlane Capital Partners (“NCP”) announced today the sale of its equity interest in VMG Health (the “Company’) to Incline Equity Partners. The Company’s extensive employee shareholder group will maintain its significant equity ownership position and VMG Health's executive team will continue to lead the business going forward.

SAI MedPartners (“SAI”), a leading consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries, is pleased to announce it has acquired PharmaForce International (“PharmaForce”). Northlane Capital Partners (“NCP”) partnered with management to acquire SAI in June 2022.

SAI MedPartners (“SAI”), a leading consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries, is pleased to announce it has acquired Fulcrum Research Group (“Fulcrum”). Northlane Capital Partners (“NCP”) partnered with management to acquire SAI in June 2022.

Northlane Capital Partners (“NCP”) announced today that it has made an investment in Infobase, a leading provider of cloud-based educational solutions, integrating content, tools, and technology to foster lifelong learning and deliver interactive learning experiences. NCP invested in partnership with the Infobase management team, led by CEO Paul Skordilis.

Northlane Capital Partners (“NCP”) announced today that it has made an investment in SAI MedPartners (“SAI”), a leading consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries. NCP invested in partnership with the SAI management team, led by Founder and CEO Erik Nordhoy.

Northlane Capital Partners (“NCP”) announced today that it has sold its portfolio company Discovery Data Holdings, Inc. (“Discovery”) to Institutional Shareholder Services Inc. (“ISS”), a leading provider of corporate governance and responsible investment solutions, market intelligence, fund services, and events and editorial content for institutional investors and corporations.

Northlane Capital Partners (“NCP”) announced today that it has made an investment in Choice Financial Group (“Choice”), a leading insurance agency. NCP invested in partnership with the Choice management team, led by Founder and President Richard Braun. In addition, Bob Hilb, an established insurance industry executive with more than 30 years of experience, joined the Choice executive team in conjunction with NCP’s investment.

Northlane Capital Partners (“NCP”) announced today that its portfolio company, Multi-Tech Systems, Inc. (“MultiTech”), a leading global supplier of Internet of Things (“IoT”) devices, services, and solutions, acquired Radio Bridge Inc. (“Radio Bridge”), a Minnesota-based designer and manufacturer of long-range wireless sensors for the IoT industry. This marks MultiTech’s second add-on within the past nine months.

Northlane Capital Partners (“NCP”) announced today that it has made an investment in EBS, Inc. d/b/a The Difference Card (“The Difference Card”), a leading provider of healthcare cost containment solutions. NCP invested in partnership with The Difference Card’s existing management team, led by CEO Gregg Lehman. Richard Fleder, an executive with more than 45 years of experience in the health insurance benefits industry, joined the Board of Directors in conjunction with NCP’s investment.

Northlane Capital Partners (“Northlane” or “NCP”), a middle market private equity firm targeting investments in healthcare and business services, today announced that it has successfully raised its second independent fund, Northlane Capital Partners II, L.P. (“NCP II” or “Fund II”). NCP II closed on total capital commitments of $408 million, exceeding its target of $375 million, and attracted strong interest from a diverse group of investors, including public pension funds, asset managers, insurance companies, high net worth families, foundations, and former portfolio company executives.